
It’s difficult to strike a balance between systemic anticoagulation and clotting. The endothelium manages the equilibrium between anticoagulant and prothrombotic systems in proper hemostasis. Because of the blood-surface interaction during ECLS, systemic anticoagulation is required to reduce the risk of clotting. UNFH has a short half-life, is easy to titrate at the bedside, and is…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest